Scott Siverhus, MD
Adult Reconstructive Orthopaedic Surgery · Phoenix, AZNPI 1336121102
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $12,250 of the $13,998 with a category attached, or 87.5%. Encore Medical, LP accounts for 94.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $11,272 and has fallen 97.8% since, to $248 in 2024.
Across 35 payments — averaging $399.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Encore Medical, LP$13K
- AbbVie$534
- Onkos Surgical, Inc.$138
- Boston Scientific$39
- Abbott$26
- Galderma Laboratories, L.p.$15
Across 16 payments — averaging $4364.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Encore Medical, LP$70K
What the payments were for
- Consulting fees$12,25088%
- Travel & lodging$7315%
- Food & beverage$7615%
- Education$2552%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Encore Medical, LP | 11 | $13,246 |
| AbbVie(2 entities) | 19 | $534 |
| Onkos Surgical, Inc. | 1 | $138 |
| Boston Scientific | 2 | $39 |
| Abbott | 1 | $26 |
| Galderma Laboratories, L.p. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,998 in reported general payments places this provider in the 65th percentile of 43 adult reconstructive orthopaedic surgery providers in Arizona.
See all adult reconstructive orthopaedic surgery providers in Arizona →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 713 | $8,861 |
| Celecoxib | 130 | $2,955 |
| Ibuprofen | 34 | $243 |
| Meloxicam | 76 | $204 |
| Oxycodone Hcl | 25 | $168 |
| Ondansetron Hcl | 11 | $91 |
| Tramadol Hcl | 12 | $44 |
| Amoxicillin | 24 | $42 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Phoenix
- Lige KaplanPhoenix$327K
- Jason ScalisePhoenix$60K
- Keerat SinghPhoenix$11K
- Steven WernerPhoenix$6K
- Bryan WallPhoenix$3K
- Marc RosenPhoenix$2K
- Robert PivecPhoenix$2K
- Allison SuraciPhoenix$1K
- Alexander McLarenPhoenix$1K
- Kishore TipirneniPhoenix$322
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.